aclacinomycin has been researched along with fagaronine in 2 studies
Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (fagaronine) | Trials (fagaronine) | Recent Studies (post-2010) (fagaronine) |
---|---|---|---|---|---|
168 | 8 | 21 | 39 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benoist, H; Carpentier, Y; Comoe, L; Desplaces, A; Dufer, J; Joly, P | 1 |
Broglio, C; Carpentier, Y; Desplaces, A; Dufer, J; Joly, P | 1 |
2 other study(ies) available for aclacinomycin and fagaronine
Article | Year |
---|---|
Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural kil
Topics: Aclarubicin; Alkaloids; Antigens, CD; Antineoplastic Agents; Benzophenanthridines; Cell Line; Cytotoxicity, Immunologic; Doxorubicin; Glycophorins; Hemoglobins; Humans; Immunity, Innate; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Phenanthridines; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |
Quantitative morphological assessment of erythroblastic differentiation induced, in vitro, in human K562 leukemic cells.
Topics: Aclarubicin; Alkaloids; Benzophenanthridines; Cell Differentiation; Erythroblasts; Hemin; Hemoglobins; Humans; Leukemia; Phenanthridines; Tumor Cells, Cultured | 1993 |